Germans Trias i Pujol Research Institute

What Germans Trias i Pujol Research Institute does

Germans Trias i Pujol Research Institute (IGTP) is a Spanish non-profit biomedical research foundation founded in 1996 and headquartered on the Campus Can Ruti in Badalona, Barcelona. The institute operates as an accredited Instituto de Investigación Sanitaria (IIS) under the Instituto de Salud Carlos III, employing 1,023 contracted and affiliated staff across nine core research platforms — Biobank, Biostatistics, Cytometry, Cryobiology, High Content Genomics and Bioinformatics, High Performance Computing, Microscopy, Proteomics and Metabolomics, and Translational Genomics — plus the UPIC clinical trials unit and project management services. Its research portfolio covers cancer, infectious diseases, cardiovascular and respiratory diseases, neuroscience, and rare genetic diseases, with particular depth in neurofibromatosis, schwannomatosis, myotonic dystrophy, and hereditary cancer. Strategic projects include the GCAT|Genomes for Life population genomics cohort and the CMCiB Comparative Medicine and Bioimage Centre of Catalonia.

The institute runs 366 active research projects, 986 active clinical trials, and produced 1,110 publications in 2025. Its technology stack combines proprietary preclinical platforms (iPSC-derived cellular models, Patient-Derived Orthotopic Xenograft systems, nanopore and long-read sequencing) with externally distributed bioinformatics tooling (regioneR, karyoploteR). IGTP holds 35 active patent families, maintains 19 license agreements, and supports 9 active spin-offs through the Innomed innovation platform and Corporate Engagement Program. Advanced therapy development is being scaled via the PATH program.

Revenue is generated almost entirely through public grant funding from Spanish (ISCIII, Generalitat de Catalunya), European (Horizon Europe, COST Actions, EATRIS), and charitable sources (La Marató de TV3, Children's Tumor Foundation), with a single disclosed 2025 competitive grant of €3,547,417 for the DM1-Hub national network. The institute is governed as a consortium by Generalitat de Catalunya, Universitat Autònoma de Barcelona, Institut Català de la Salut, Hospital Germans Trias i Pujol, and Institut Català d'Oncologia. Customers and collaborators include hospitals, universities, patient associations, and industry partners (HealX, CureAge Therapeutics, NIH/NCATS), reflecting a translational research model that bridges academic science and clinical application rather than a commercial product model.

Name

Germans Trias i Pujol Research Institute

Legal name

Fundació Institut de Recerca en Ciències de la Salut Germans Trias i Pujol

Website

https://germanstrias.org

Company type

Private

Founded year

1996

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Germans Trias i Pujol Research Institute (IGTP) is a Spanish non-profit biomedical research foundation operating nine core technology platforms and 366 active projects across cancer, rare diseases, and infectious disease, serving hospitals, universities, and patients from the Campus Can Ruti in Badalona, Barcelona.

Ownership category

akta.pro rank

Product category

Biomedical Research Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Testing Laboratories and Services (541380)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Molecular Diagnostics & Genomics Laboratories (HLAFAMAE)

akta.pro secondary industries

Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD), Genomics & Molecular Diagnostics (Trial Support) (HLAGAEAD)

Keywords

• Biomedical research services
• Translational research
• Clinical genomics
• Core research facilities
• Rare disease research

Headquarters

HQ city

Barcelona

HQ country

Spain

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

1. Research Grants and Institutional Funding: Government funding from Instituto de Salud Carlos III, European Commission (Horizon Europe, COST Actions), and regional authorities (Generalitat de Catalunya).

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Germans Trias i Pujol Research Institute (IGTP) is a non-profit biomedical research institute operating a portfolio of core research platforms and technology services that support translational research. It provides biobanking, biostatistics, cytometry, cryobiology, high-content genomics and bioinformatics, high-performance computing, microscopy, proteomics and metabolomics, translational genomics, clinical trial support (UPIC), and project management services focused on cancer genetics, rare diseases, infectious diseases, and neuromuscular disorders.

Product overview

Germans Trias i Pujol Research Institute (IGTP) is a biomedical research institute offering a platform of core facilities and technology services for the research community. The portfolio includes nine specialized core facilities (Biobank, Biostatistics, Cytometry, Cryobiology, High Content Genomics and Bioinformatics, High Performance Computing, Microscopy, Proteomics and Metabolomics, and Translational Genomics), two service units (Clinical Trials Unit UPIC and Project Management), research programs such as the CARE Cancer Research Program, and strategic projects including CMCiB (Comparative Medicine and Bioimage Centre of Catalonia) and GCAT Genomes for Life. Innovation support is provided through the Innomed program and Corporate Engagement Program.

Differentiator

Problem solved

Functional benefit

Brands

• GCAT|Genomes for Life: A strategic project focusing on genomics and life sciences research
• CMCiB
• PATH
• CARE Program

Products and services

• Biobank A core facility providing biobanking services for storing and managing biological samples for research purposes.
• Biostatistics Statistical analysis services and support for research projects requiring advanced biostatistical methods.
• Cytometry Flow cytometry services for cell analysis and sorting in biomedical research applications.
• Cryobiology Cryopreservation services for biological samples including cells, tissues, and genetic materials.
• High Content Genomics and Bioinformatics Genomics analysis services combined with bioinformatics computational support for large-scale genomic data processing and interpretation.
• High Performance Computing Supercomputing infrastructure and computational resources for processing large-scale research data and simulations.
• Microscopy Advanced microscopy imaging services for cellular and tissue analysis in research applications.
• Proteomics and Metabolomics Mass spectrometry-based proteomics and metabolomics analysis services for biomarker discovery and molecular characterization.
• Translational Genomics Genomic analysis services focused on translating research findings into clinical applications.
• Clinical Trials Unit (UPIC) Multipurpose Clinical Research Unit providing infrastructure and support for conducting clinical trials and translational research.
• Project Management Professional project management services for coordinating and supporting research projects from conception to completion.
• CARE Program (Cancer Research) Translational Cancer Research Program promoting interdisciplinary collaboration between basic and clinical researchers to advance cancer prevention, diagnosis, and treatment.
• CMCiB - Comparative Medicine and Bioimage Centre of Catalonia Strategic research infrastructure focused on comparative medicine and advanced bioimaging technologies.
• GCAT | Genomes for Life Large-scale population genomics study investigating the relationship between genetics, lifestyle, and health outcomes.
• Innomed Innovation platform supporting biomedical entrepreneurship and technology transfer initiatives.
• Corporate Engagement Program (CEP) Program facilitating collaboration between IGTP researchers and industry partners for biomedical innovation.

Quantifiable outcome

• Published in high-impact journals including Nature Communications, Clinical Cancer Research, Cell Reports, and The Lancet

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

15 partnerships are on record, tiered core and minor.

• Universitat Autònoma de Barcelona (UAB)coreStrategic or Co-development PartnerUniversity partnership for academic collaboration, research supervision, and doctoral programs. UAB is a key governance partner of IGTP.
• Institut Català d'Oncologia (ICO)coreStrategic or Co-development PartnerCollaborative cancer research including hereditary cancer programs, NF1 research, and joint clinical activities on Campus Can Ruti.
• Institut GuttmanncoreStrategic or Co-development PartnerCollaboration on neurorehabilitation research and brain-related disorders on Campus Can Ruti.
• Institut de Recerca Contra la Leucèmia Josep CarrerasminorStrategic or Co-development PartnerBlood cancer and leukemia research collaboration within the Campus Can Ruti ecosystem.
• IrsiCaixacoreStrategic or Co-development PartnerAIDS research institute collaboration for infectious disease research including COVID-19 genomic surveillance.
• EATRIScoreStrategic or Co-development PartnerEuropean infrastructure for translational medicine providing access to research services and collaboration networks across Europe.
• Hospital Germans Trias i PujolcoreStrategic or Co-development PartnerCore clinical partner providing patient access, clinical trial infrastructure, and translation of research findings.
• Children's Tumor Foundation (CTF)coreStrategic or Co-development PartnerFunding and collaboration for neurofibromatosis research, including drug discovery initiatives and iPSC model development.
• European Cooperation in Science and Technology (COST)coreStrategic or Co-development PartnerEuropean network coordination enabling IGTP to lead INTERACT-NF COST Action with 68 researchers from 13 countries.
• HealXminorStrategic or Co-development PartnerAI-powered biotechnology company conducting Phase 2 clinical trial for NF1 treatment (HLX-1502) using IGTP-developed iPSC models.
• CureAge TherapeuticsminorStrategic or Co-development PartnerGene therapy company developing treatments for peripheral nerve diseases starting with NF1, utilizing IGTP research models.
• National Institutes of Health (NIH) / NCATScoreStrategic or Co-development PartnerCollaboration with Dr. Marc Ferrer's lab at NCATS for iPSC-based drug discovery and MPNST research.
• European Reference Network (ERN) GENTURIScoreStrategic or Co-development PartnerEuropean network for rare tumor syndromes connecting healthcare providers and expert centers for neurofibromatosis and related conditions.
• European Neurofibromatosis Group (ENFG)coreStrategic or Co-development PartnerEuropean research network organizing biennial NF conferences and promoting collaborative NF research across Europe.
• CIBERONCcoreStrategic or Co-development PartnerSpanish Biomedical Research Center Network in Cancer for collaborative cancer research programs.

Scale indicators7 records

Recent moves7 records

Expansion highlights5 records

Others

• EATRIS (European Infrastructure for Translational Medicine): European consortium of translational medicine infrastructure providers of which IGTP is a member. Listed as a peer because IGTP operates within this network; relevant as an ecosystem reference rather than a direct competitor.

Direct peers

• Spanish National Cancer Research Centre (CNIO): Spain's leading cancer research center with similar translational focus, IIS-aligned governance, and strong publication/patent output. Directly comparable as a peer IIS-accredited research institute.
• Vall d'Hebron Institute of Oncology (VHIO): Barcelona-based translational cancer research institute closely comparable to IGTP. Both are IIS-accredited centers affiliated with major Catalan university hospitals and active in precision oncology, clinical trials, and spin-off creation.
• Centre for Genomic Regulation (CRG): Barcelona-based biomedical research institute focused on genomics, bioinformatics, and cellular biology. Directly comparable in scientific scope (genomics, proteomics, HPC) and translational orientation.
• Josep Carreras Leukaemia Research Institute: Catalan-based hematological malignancy research institute located on the same Campus Can Ruti. Direct peer in disease-specific translational research, IIS-style governance, and patient-driven research model.
• IRB Barcelona: Catalan biomedical research institute focused on cancer, ageing, and computational biology. Comparable as a Catalonia-based life sciences research institute with similar core platform infrastructure and translational ambitions.

Broad incumbents

• Helmholtz Zentrum München: German research center for environmental health and biomedical research. Comparable as a large European translational research institute with similar IIS-equivalent status and mixed public funding model.
• Institut Pasteur: Paris-based foundational biomedical research institute with infectious disease, genomics, and translational programs. Comparable in translational scope, public funding model, and international research network leadership.
• Wellcome Sanger Institute: UK-based genomics and biodata institute. Comparable in genomic sequencing and bioinformatics capability, though at much greater scale and with a global rather than European-regional focus.
• Karolinska Institutet: One of Europe's largest and most prestigious medical research universities. Comparable as a translational medicine powerhouse, though significantly larger in scale and broader in scope than IGTP.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/gtrecerca
• Facebookfacebook.com/igtpresearch
• LinkedInlinkedin.com/company/igtp
• Instagraminstagram.com/igtp_research

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Germans Trias i Pujol Research Institute